These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33287338)

  • 1. HDL Proteome and Alzheimer's Disease: Evidence of a Link.
    Marsillach J; Adorni MP; Zimetti F; Papotti B; Zuliani G; Cervellati C
    Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33287338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review.
    Zimetti F; Adorni MP; Marsillach J; Marchi C; Trentini A; Valacchi G; Cervellati C
    Oxid Med Cell Longev; 2021; 2021():6695796. PubMed ID: 33505588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.
    Poliakova T; Wellington CL
    Mol Neurodegener; 2023 Nov; 18(1):86. PubMed ID: 37974180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage.
    Cervellati C; Vigna GB; Trentini A; Sanz JM; Zimetti F; Dalla Nora E; Morieri ML; Zuliani G; Passaro A
    Atherosclerosis; 2019 Jun; 285():64-70. PubMed ID: 31029939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer's Disease.
    Chan HC; Ke LY; Lu HT; Weng SF; Chan HC; Law SH; Lin IL; Chang CF; Lu YH; Chen CH; Chu CS
    Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33256187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.
    Zhao XJ; Liu LC; Guo C; Shen WW; Cao J; Du F; Wu DF; Yu H
    Ann Transl Med; 2021 Jul; 9(13):1063. PubMed ID: 34422975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer's Disease Patients.
    Berezhnoy G; Laske C; Trautwein C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum HDL Associated Antioxidant Activity in Alzheimer's Disease: Paraoxonase1 and Dysfunctional HDL.
    Varlibas F; Akhan O; Can M; Yuksel G; Gul ZB
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of High-Density Lipoprotein in Lowering Risk of Dementia in the Elderly: A Review.
    Anusheel ; Avula SN; Joseph KN; Onuchukwu CV; Thondamala V; Shrivastava S; Namburi AR; Mohammed L
    Cureus; 2022 Apr; 14(4):e24374. PubMed ID: 35621297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).
    Tynkkynen J; Hernesniemi JA; Laatikainen T; Havulinna AS; Sundvall J; Leiviskä J; Salo P; Salomaa V
    Age (Dordr); 2016 Dec; 38(5-6):465-473. PubMed ID: 27663235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis.
    Borràs C; Mercer A; Sirisi S; Alcolea D; Escolà-Gil JC; Blanco-Vaca F; Tondo M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume.
    Pedrini S; Doecke JD; Hone E; Wang P; Thota R; Bush AI; Rowe CC; Dore V; Villemagne VL; Ames D; Rainey-Smith S; Verdile G; Sohrabi HR; Raida MR; Taddei K; Gandy S; Masters CL; Chatterjee P; Martins RN;
    J Neurochem; 2022 Oct; 163(1):53-67. PubMed ID: 36000528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease.
    Bergt C; Nakano T; Ditterich J; DeCarli C; Eiserich JP
    Free Radic Biol Med; 2006 Nov; 41(10):1542-7. PubMed ID: 17045922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of serum lipids levels of Alzheimer's disease patients with sex, age and apolipoprotein E gene polymorphism].
    Ma RM; Li GG; Ding YW; Lyu J; Shao CQ; Liu JZ; Liu J; Zhang GJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Mar; 56(3):280-286. PubMed ID: 35381648
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E.
    Robert J; Button EB; Martin EM; McAlary L; Gidden Z; Gilmour M; Boyce G; Caffrey TM; Agbay A; Clark A; Silverman JM; Cashman NR; Wellington CL
    Mol Neurodegener; 2020 Mar; 15(1):23. PubMed ID: 32213187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer's disease and vascular dementia.
    Alam R; Tripathi M; Mansoori N; Parveen S; Luthra K; Lakshmy R; Sharma S; Arulselvi S; Mukhopadhyay AK
    Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):769-76. PubMed ID: 24965284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.
    Cervellati C; Valacchi G; Tisato V; Zuliani G; Marsillach J
    Minerva Med; 2019 Jun; 110(3):238-250. PubMed ID: 30334443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease.
    Agarwal R; Talwar P; Kushwaha SS; Tripathi CB; Kukreti R
    Ann Indian Acad Neurol; 2015; 18(3):320-6. PubMed ID: 26425011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice.
    Srivastava R; Yu S; Parks BW; Black LL; Kabarowski JH
    Arthritis Rheum; 2011 Jan; 63(1):201-11. PubMed ID: 20882670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.